Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates.
Saved in:
| Title: | Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates. |
|---|---|
| Authors: | Nagayama A; Department of Surgery (Breast Group), Keio University School of Medicine, Tokyo, Japan., Vidula N; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Bardia A; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA. |
| Source: | Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2021 May 13; Vol. 35 (5), pp. 249-254. Date of Electronic Publication: 2021 May 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Electronic Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33983696 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nagayama+A%22">Nagayama A</searchLink>; Department of Surgery (Breast Group), Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Vidula+N%22">Vidula N</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bardia+A%22">Bardia A</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228712059%22">Oncology (Williston Park, N.Y.)</searchLink> [Oncology (Williston Park)] 2021 May 13; Vol. 35 (5), pp. 249-254. <i>Date of Electronic Publication: </i>2021 May 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MultiMedia+Healthcare%22">MultiMedia Healthcare </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8712059 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>0890-9091 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208909091%22">08909091 </searchLink><i>NLM ISO Abbreviation: </i>Oncology (Williston Park) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33983696 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.46883/ONC.2021.3505.0249 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 249 Titles: – TitleFull: Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nagayama A – PersonEntity: Name: NameFull: Vidula N – PersonEntity: Name: NameFull: Bardia A IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 05 Text: 2021 May 13 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 0890-9091 Numbering: – Type: volume Value: 35 – Type: issue Value: 5 Titles: – TitleFull: Oncology (Williston Park, N.Y.) Type: main |
| ResultId | 1 |
